tiprankstipranks
Lucid Diagnostics’ Strategic Financial Maneuvering and Agreements
PremiumCompany AnnouncementsLucid Diagnostics’ Strategic Financial Maneuvering and Agreements
2M ago
Lucid Diagnostics submits clinical evidence for EsoGuard Esophagea DNA test
Premium
The Fly
Lucid Diagnostics submits clinical evidence for EsoGuard Esophagea DNA test
2M ago
Lucid Diagnostics Reports Q3 Revenue Growth and Strategic Expansion
Premium
Company Announcements
Lucid Diagnostics Reports Q3 Revenue Growth and Strategic Expansion
2M ago
Lucid Diagnostics granted patent underlying its EsoGuard Esophageal DNA Ttest
PremiumThe FlyLucid Diagnostics granted patent underlying its EsoGuard Esophageal DNA Ttest
3M ago
Castle Biosciences price target raised to $40 from $35 at BTIG
Premium
The Fly
Castle Biosciences price target raised to $40 from $35 at BTIG
3M ago
Lucid Diagnostics management to meet virtually with BTIG
Premium
The Fly
Lucid Diagnostics management to meet virtually with BTIG
4M ago
Lucid Diagnostics reports Q2 EPS (20c), consensus (22c)
PremiumThe FlyLucid Diagnostics reports Q2 EPS (20c), consensus (22c)
5M ago
Lucid Diagnostics’ EsoGuard esophageal precancer testing shows efficacy
Premium
The Fly
Lucid Diagnostics’ EsoGuard esophageal precancer testing shows efficacy
6M ago
Lucid Diagnostics announces record quarterly EsoGuard test volume
Premium
The Fly
Lucid Diagnostics announces record quarterly EsoGuard test volume
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100